He potential for frustration, time-wasting, and bad feelings between pharma and biotech partners is enormous. That some successful decisions are made under these circumstances is something of a miracle.
Stuart Kliman
Advertisement
Articles by Stuart Kliman
Advertisement
Latest Updated Articles
The Human Side of PartnershipsOctober 1st 2004
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Reportedly Pauses National Priority Voucher Pilot and Pauses CRL Publication
2
Zai Lab’s Long-Acting Atopic Dermatitis Bispecific Points to Every-12-Week Dosin
3
What 3 Principles Guide Merck's Biologics and ADC Capacity Placement?
4
FDA Grants Kamau RMAT Designation to Nula-cel for Sickle Cell Disease
5